# IMCR (Immunocore Holdings plc) - SEC EDGAR Financial Statements

> Immunocore Holdings plc reported $429.3M in revenue and a net loss of $32.12M for the trailing twelve months ended September 30, 2026 (down 1.4% year over year), with a 98.9% gross margin and a -6.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/IMCR
- Markdown: https://convexityos.com/fundamentals/IMCR.md
- SEC CIK: 0001671927
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:25 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001671927&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $429.3M | -1.4% YoY |
| Operating Income | TTM | -$29.02M | -6.8% margin |
| Net Income | TTM | -$32.12M | -7.5% net margin |
| Diluted EPS | TTM | -$0.62 | Split-adjusted |
| Free Cash Flow | TTM | -$18.20M | -4.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $901.3M | Total debt: $40.99M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $400.0M | $310.2M | $249.4M | $174.4M | $36.48M |
| Cost of Revenue | $5.09M | $2.73M | $1.04M | $1.09M | $0 |
| **Gross Profit** | $394.9M | $307.5M | $248.4M | $173.3M | $36.48M |
| Research & Development | $274.9M | $222.2M | $163.5M | $101.9M | $100.2M |
| Selling, General & Admin | $165.4M | $155.8M | $144.5M | $123.1M | $110.8M |
| **Operating Income** | -$45.35M | -$70.46M | -$59.65M | -$51.71M | -$174.6M |
| **EBITDA** | -$42.25M | -$66.26M | -$55.55M | -$46.41M | -$167.0M |
| Interest Income | $16.48M | $25.62M | $17.99M | $3.76M | $65K |
| Interest Expense | $12.17M | $18.84M | $5.15M | $5.41M | $5.57M |
| Income Before Tax | -$19.10M | -$52.94M | -$60.89M | -$40.88M | -$179.9M |
| Income Tax Expense | $16.41M | -$1.85M | -$5.60M | $11.66M | $150K |
| **Net Income** | -$35.51M | -$51.09M | -$55.29M | -$52.54M | -$180.0M |
| Basic EPS | -$0.71 | -$1.02 | -$1.13 | -$1.15 | -$4.24 |
| **Diluted EPS** | -$0.71 | -$1.02 | -$1.13 | -$1.15 | -$4.24 |
| Basic Shares Outstanding | 50.3M | 50.0M | 48.9M | 45.7M | 42.5M |
| Diluted Shares Outstanding | 50.3M | 50.0M | 48.9M | 45.7M | 42.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $102.2M | $115.9M | $106.7M | $104.5M | $103.7M | $97.96M | $93.88M | $84.05M |
| Cost of Revenue | $676K | $1.09M | $434K | $2.70M | $513K | $1.04M | $831K | $330K |
| **Gross Profit** | $101.5M | $114.8M | $106.2M | $101.8M | $103.2M | $96.92M | $93.05M | $83.72M |
| Research & Development | $74.70M | $73.94M | $61.11M | $78.82M | $70.57M | $69.01M | $56.47M | $60.85M |
| Selling, General & Admin | $40.45M | $43.89M | $37.85M | $42.65M | $39.78M | $42.79M | $40.20M | $42.32M |
| **Operating Income** | -$13.61M | -$3.00M | $7.28M | -$19.69M | -$7.17M | -$14.88M | -$3.62M | -$19.45M |
| **EBITDA** | -$12.50M | -$1.97M | $8.23M | -$18.86M | -$6.37M | -$14.10M | -$2.76M | -$18.29M |
| Interest Income | $3.61M | $3.58M | $3.42M | $3.91M | $4.12M | $4.27M | $4.18M | $5.17M |
| Interest Expense | $3.06M | $3.06M | $3.05M | $3.05M | $3.04M | $3.04M | $3.02M | $7.04M |
| Income Before Tax | -$14.07M | -$514K | $13.27M | -$15.79M | $304K | -$9.69M | $6.08M | -$24.82M |
| Income Tax Expense | $153K | $294K | $301K | $14.27M | $481K | $606K | $1.06M | -$1.05M |
| **Net Income** | -$14.22M | -$808K | $12.97M | -$30.06M | -$177K | -$10.30M | $5.02M | -$23.77M |
| Basic EPS | -$0.28 | -$0.02 | $0.26 | -- | $0.00 | -$0.20 | $0.10 | -- |
| **Diluted EPS** | -$0.28 | -$0.02 | $0.25 | -- | $0.00 | -$0.20 | $0.10 | -- |
| Basic Shares Outstanding | 51.6M | 51.0M | 50.8M | -- | 50.4M | 50.3M | 50.1M | -- |
| Diluted Shares Outstanding | 51.6M | 51.0M | 52.9M | -- | 50.4M | 50.3M | 51.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $467.7M | $455.7M | $442.6M | $402.5M |
| Short-Term Investments | $396.4M | $364.6M | $0 | -- |
| **Cash & Short-Term Investments** | $864.2M | $820.4M | $442.6M | $402.5M |
| Accounts Receivable, Net | -- | $63.01M | $52.09M | $33.58M |
| Inventory | $6.74M | $5.45M | $4.50M | $692K |
| Other Current Assets | $6.75M | $7.90M | $9.71M | $3.62M |
| **Total Current Assets** | $996.7M | $929.9M | $528.8M | $474.0M |
| Property, Plant & Equipment, Net | $11.46M | $10.09M | $9.21M | $7.83M |
| Other Non-Current Assets | $20.28M | $17.12M | $14.47M | $8.89M |
| **Total Non-Current Assets** | $70.53M | $79.64M | $68.18M | $52.78M |
| **Total Assets** | $1.07B | $1.01B | $597.0M | $526.8M |
| Accounts Payable | $24.36M | $25.10M | $17.80M | $14.45M |
| Deferred Revenue (Current) | $583K | $0 | $0 | $7.76M |
| **Total Current Liabilities** | $246.7M | $212.2M | $139.0M | $100.8M |
| Deferred Revenue (Non-Current) | $4.86M | $5.43M | $5.51M | $5.24M |
| **Total Non-Current Liabilities** | $439.5M | $436.6M | $89.14M | $87.02M |
| **Total Liabilities** | $686.2M | $648.8M | $228.2M | $187.9M |
| **Total Debt (incl. Leases)** | $43.56M | $41.71M | $36.02M | $33.64M |
| Common Stock | $136K | $135K | $134K | $129K |
| Retained Earnings | -$831.3M | -$795.8M | -$744.7M | -$689.4M |
| Accumulated Other Comp. Income | -$28.08M | -$33.76M | -$36.26M | -$54.67M |
| **Total Stockholders' Equity** | $381.0M | $360.7M | $368.8M | $338.9M |
| Total Equity | $381.0M | $360.7M | $368.8M | $338.9M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $512.2M | $484.9M | $452.7M | $467.7M | $498.4M | $487.9M | $476.8M | $455.7M |
| Short-Term Investments | $389.1M | $395.3M | $392.2M | $396.4M | $393.9M | $394.9M | $360.2M | $364.6M |
| **Cash & Short-Term Investments** | $901.3M | $880.2M | $844.9M | $864.2M | $892.4M | $882.8M | $837.0M | $820.4M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $63.01M |
| Inventory | $7.47M | $7.79M | $8.25M | $6.74M | $5.66M | $5.46M | $6.80M | $5.45M |
| Other Current Assets | -- | -- | -- | $6.75M | -- | -- | -- | $7.90M |
| **Total Current Assets** | $1.06B | $1.05B | $1.00B | $996.7M | $1.02B | $1.00B | $948.6M | $929.9M |
| Property, Plant & Equipment, Net | $14.05M | $12.86M | $12.13M | $11.46M | $9.43M | $9.55M | $9.77M | $10.09M |
| Other Non-Current Assets | $18.48M | $18.50M | $18.61M | $20.28M | $16.49M | $17.04M | $17.13M | $17.12M |
| **Total Non-Current Assets** | $68.81M | $68.38M | $68.29M | $70.53M | $79.65M | $80.09M | $79.38M | $79.64M |
| **Total Assets** | $1.13B | $1.12B | $1.07B | $1.07B | $1.10B | $1.08B | $1.03B | $1.01B |
| Accounts Payable | $21.39M | $26.32M | $30.16M | $24.36M | $22.96M | $23.86M | $29.11M | $25.10M |
| Deferred Revenue (Current) | $573K | $573K | $572K | $583K | $582K | $594K | -- | $0 |
| **Total Current Liabilities** | $229.6M | $235.2M | $240.1M | $246.7M | $170.4M | $170.1M | $149.2M | $212.2M |
| Deferred Revenue (Non-Current) | $4.34M | $4.49M | $4.62M | $4.86M | $5.00M | $5.25M | $5.61M | $5.43M |
| **Total Non-Current Liabilities** | $479.9M | $464.4M | $438.3M | $439.5M | $535.6M | $523.8M | $500.4M | $436.6M |
| **Total Liabilities** | $709.5M | $699.6M | $678.4M | $686.2M | $705.9M | $693.9M | $649.5M | $648.8M |
| **Total Debt (incl. Leases)** | $40.99M | $40.75M | $42.02M | $43.56M | $43.27M | $44.40M | $42.47M | $41.71M |
| Common Stock | $139K | $138K | $137K | $136K | $135K | $135K | $135K | $135K |
| Retained Earnings | -$833.3M | -$819.1M | -$818.3M | -$831.3M | -$801.2M | -$801.0M | -$790.7M | -$795.8M |
| Accumulated Other Comp. Income | -$33.68M | -$34.33M | -$35.37M | -$28.08M | -$30.01M | -$26.61M | -$33.09M | -$33.76M |
| **Total Stockholders' Equity** | $419.7M | $419.8M | $393.7M | $381.0M | $396.6M | $388.5M | $378.5M | $360.7M |
| Total Equity | $419.7M | $419.8M | $393.7M | $381.0M | $396.6M | $388.5M | $378.5M | $360.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$35.51M | -$51.09M | -$55.29M | -$52.54M | -$180.0M |
| Depreciation & Amortization | $3.10M | $4.20M | $4.10M | $5.30M | $7.60M |
| Stock-Based Compensation | $37.70M | $34.19M | $32.47M | $32.89M | $48.89M |
| Change in Receivables | -$7.34M | -$12.35M | -$17.87M | -$26.26M | -$4.86M |
| Change in Payables | -$2.46M | $7.27M | $2.62M | $4.91M | $1.47M |
| **Operating Cash Flow** | -$10.71M | $26.06M | $2.94M | -$49.21M | -$143.1M |
| Capital Expenditure | -$4.34M | -$5.17M | -$5.42M | -$2.20M | -$1.39M |
| **Free Cash Flow** | -$15.05M | $20.89M | -$2.48M | -$51.41M | -$144.5M |
| Purchases of Investments | -$30.00M | -$350.0M | $0 | $0 | -- |
| **Investing Cash Flow** | -$16.34M | -$355.1M | -$5.42M | -$2.20M | -$1.28M |
| **Financing Cash Flow** | $12.37M | $343.9M | $34.35M | $145.4M | $288.2M |
| **Net Change in Cash** | -$14.68M | $14.81M | $31.86M | $94.04M | $143.8M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.22M | -$808K | $12.97M | -$30.06M | -$177K | -$10.30M | $5.02M | -$23.77M |
| Depreciation & Amortization | $1.11M | $1.03M | $948K | $834K | $798K | $780K | $854K | $1.17M |
| Stock-Based Compensation | $9.73M | $9.40M | $6.30M | $8.34M | $9.84M | $10.03M | $9.49M | $8.67M |
| Change in Receivables | $6.75M | -$14.62M | -$7.93M | $1.99M | -$5.99M | -$4.18M | $836K | -$1.29M |
| Change in Payables | -$5.15M | -$4.80M | $5.97M | $1.42M | -$287K | -$6.93M | $3.34M | $5.88M |
| **Operating Cash Flow** | $20.09M | $15.93M | -$13.78M | -$32.66M | -$4.46M | $25.96M | $435K | -$13.95M |
| Capital Expenditure | -$2.35M | -$786K | -$1.78M | -$2.88M | -$748K | -$414K | -$298K | -$3.58M |
| **Free Cash Flow** | $17.74M | $15.14M | -$15.56M | -$35.53M | -$5.20M | $25.55M | $137K | -$17.54M |
| **Investing Cash Flow** | $4.65M | -$786K | $4.22M | -$880K | $5.25M | -$30.41M | $9.70M | -$3.54M |
| **Financing Cash Flow** | $3.75M | $16.48M | $656K | $4.28M | $1.87M | $3.67M | $2.55M | -$51.51M |
| **Net Change in Cash** | $28.50M | $31.63M | -$8.90M | -$29.25M | $2.66M | -$780K | $12.69M | -$69.00M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.7% | 99.1% | 99.6% | 99.4% | 100.0% |
| **Operating Margin** | -11.3% | -22.7% | -23.9% | -29.7% | -478.5% |
| **Net Profit Margin** | -8.9% | -16.5% | -22.2% | -30.1% | -493.4% |
| Return on Equity (ROE) | -9.3% | -14.2% | -15.0% | -15.5% | -- |
| Return on Assets (ROA) | -3.3% | -5.1% | -9.3% | -10.0% | -- |
| Current Ratio | 4.04x | 4.38x | 3.80x | 4.70x | -- |
| Quick Ratio | 4.01x | 4.36x | 3.77x | 4.69x | -- |
| Debt to Equity | 0.11x | 0.12x | 0.10x | 0.10x | -- |
| **Revenue Growth (YoY)** | +29.0% | +24.4% | +43.1% | +377.9% | -- |
| Gross Profit Growth (YoY) | +28.4% | +23.8% | +43.4% | +374.9% | -- |
| Operating Cash Flow Growth (YoY) | -141.1% | +786.4% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -172.1% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.9% | 98.9% | 98.9% | 98.7% | 99.3% | 99.3% | 99.0% | 99.1% |
| **Operating Margin** | -6.8% | -5.2% | -8.3% | -11.3% | -11.9% | -13.0% | -14.3% | -22.7% |
| **Net Profit Margin** | -7.5% | -4.2% | -6.7% | -8.9% | -7.7% | -5.7% | -6.5% | -16.5% |
| Return on Equity (ROE) | -7.7% | -4.3% | -7.0% | -9.3% | -7.4% | -5.2% | -5.7% | -14.2% |
| Return on Assets (ROA) | -2.8% | -1.6% | -2.6% | -3.3% | -2.7% | -1.9% | -2.1% | -5.1% |
| Current Ratio | 4.62x | 4.47x | 4.18x | 4.04x | 6.00x | 5.89x | 6.36x | 4.38x |
| Quick Ratio | 4.59x | 4.44x | 4.15x | 4.01x | 5.97x | 5.86x | 6.31x | 4.36x |
| Debt to Equity | 0.10x | 0.10x | 0.11x | 0.11x | 0.11x | 0.11x | 0.11x | 0.12x |
| **Revenue Growth (YoY)** | -1.4% | +18.3% | +13.6% | +24.3% | +29.2% | +29.9% | +33.2% | +19.8% |
| Gross Profit Growth (YoY) | -1.6% | +18.5% | +14.2% | +21.6% | +29.3% | +31.5% | +32.4% | +19.7% |
| **Net Income Growth (YoY)** | -- | -- | +158.2% | -- | -102.0% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | +160.0% | -- | -100.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -38.7% | -3266.7% | -- | -121.1% | +10.6% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -40.7% | -11454.7% | -- | -125.6% | +10.4% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
